Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01442597 · ClinicalTrials.gov registry record · Phase 1

Computer Based Training in Cognitive Behavioral Therapy Web-based

A Phase 1 study of Substance Abuse, sponsored by Yale University.

Completed
Registry status
Phase 1
Development phase
164
Enrollment target
1
Study location

NCT01442597: Completed Phase 1 study of Substance Abuse, sponsored by Yale University.

NCT01442597 is a Phase 1 study of Substance Abuse that has completed, run by Yale University. The registered enrollment target is 164 participants, below the 5,257-participant average among 58 other Substance Abuse trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01442597, a Phase 1 study of Substance Abuse, has completed, sponsored by Yale University.

COMPLETED
Registry status
Phase 1
Development phase
164 participants
Enrollment target
1
Study location

Study Summary

The investigators are conducting a randomized clinical trial of our new web-based version of the CBT4CBT program to evaluate its effectiveness relative to standard outpatient counseling at SATU. The computer-based training program (CBT4CBT) focuses on teaching basic coping skills, presenting examples of effective use of coping skills in a number of realistic situations in video form, and providing opportunities for patients to practice and review new skills while receiving substance abuse treatment.

Conditions Studied

Interventions

  • BEHAVIORAL Standard Treatment As Usual (TAU)
  • BEHAVIORAL Individual clinician-provided CBT
  • BEHAVIORAL CBT4CBT

Study Locations (1)

Connecticut

  • Substance Abuse Treatment Unit (SATU) - New Haven

Trial Details

FieldValue
Enrollment Target 164 participants
Start Date 2012-01
Est. Completion 2018-01
Phase Phase 1
Yale University

1,492 total trials

What the finished NCT01442597 record still lists

NCT01442597 is an interventional study that assigns participants to a tested intervention. The registered 164 participants enrollment target is mid-sized for trials with a published cap, below the 5,257-participant average among 58 other Substance Abuse trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Substance Abuse appearing as the primary indexed condition, and to 3 interventions - of which Standard Treatment As Usual (TAU) is the first listed.

NCT01442597 reports a single indexed study location in Connecticut.

Frequently Asked Questions

What is clinical trial NCT01442597 about?

NCT01442597 is a clinical study titled "Computer Based Training in Cognitive Behavioral Therapy Web-based". The investigators are conducting a randomized clinical trial of our new web-based version of the CBT4CBT program to evaluate its effectiveness relative to standard outpatient counseling at SATU. The computer-based training program (CBT4CBT) focuses on teaching basic coping skills, presenting example...

What is the current status of trial NCT01442597?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 164 participants. The study started on 2012-01. Estimated completion is 2018-01.

What conditions does trial NCT01442597 study?

This clinical trial studies the following conditions: Substance Abuse.

What interventions are being tested in trial NCT01442597?

The interventions under investigation include: Standard Treatment As Usual (TAU) (BEHAVIORAL), Individual clinician-provided CBT (BEHAVIORAL), CBT4CBT (BEHAVIORAL).

Who is sponsoring clinical trial NCT01442597?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01442597 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance Abuse

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01442597's enrollment target sits among peer trials

164 27th of 58 higher than 31 of 58 other Substance Abuse trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Substance Abuse trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04891289 · 164 participants · Phase 2

    Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery

  • NCT04893226 · 164 participants · NA

    Time-Restricted Feeding Intervention in Metabolically-Unhealthy Postmenopausal Women

  • NCT05270213 · 164 participants · Phase 1

    Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors

  • NCT05543681 · 164 participants · Phase 2

    Clinical Trial on Agitation in Alzheimer's Dementia

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01442597, the US trial registry maintained by the National Library of Medicine. NCT01442597 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.